RESUMO
The methicillin-resistant Staphylococci [MRS] have an important place in the nosocomial infection. They are remarquably resistant to many antibiotics except for glycopeptids who keep their activity. However, resistant cases have been signaled in the last few years. This work was designed to assess the resistance of MRS to glycopeptids and to other antibiotics. Material and methods: 40 MRS were isolated from hospitalized patients, their resistance for glycopeptids has been studied by the E-test methods. resistance to the other antibiotics [used in the staphylococcus infections], showed, 27 to 75%. Relating to glycopeptids, no resistance to Vancomycin, 5% to Teicoplanine. 10% of the MRS studied had an intermediate sensitivity for this last. this situation indicates that it is necessary to pay attention for the MRS nosocomial infections. Many studies showed that measures relatively within our reach proved to be utility for overcoming such infections. Also glycopeptids must not be prescribed expect in necessary cases after a bacteriological examination